Unknown

Dataset Information

0

Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Clinical Trials.


ABSTRACT:

Aims

To compare the efficacy and safety of vonoprazan-based versus proton pump inhibitor (PPI)-based triple therapy in the eradication of Helicobacter pylori.

Methods

We performed a systematic search in PubMed, Embase, and the Cochrane Library databases for relevant randomized controlled trials up to March 2019. Studies were included if they compared the efficacy and safety of H. pylori eradication of vonoprazan-based and PPI-based triple therapy.

Results

Three studies with 897 patients were evaluated in this meta-analysis. The H. pylori eradication rate of vonoprazan-based triple therapy was higher than that of PPI-based triple therapy as first-line regimens (intention-to-treat analysis: pooled eradication rates, 91.4% vs 74.8%; odds ratio [OR], 3.68; 95% confidence interval (CI): [1.87-7.26]; P<0.05). The incidence of adverse events in vonoprazan-based triple therapy was lower than that in PPI-based triple therapy (pooled incidence, 32.7% vs 40.5%; OR, 0.71; 95%CI: [0.53-0.95]; P<0.05).

Conclusions

Efficacy of vonoprazan-based triple therapy is superior to that of PPI-based triple therapy for first-line H. pylori eradication. Additionally, vonoprazan-based triple therapy is better tolerated than PPI-based triple therapy.

SUBMITTER: Lyu QJ 

PROVIDER: S-EPMC6532346 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for <i>Helicobacter pylori</i> Eradication: A Meta-Analysis of Randomized Clinical Trials.

Lyu Qiu-Ju QJ   Pu Qiang-Hong QH   Zhong Xian-Fei XF   Zhang Jin J  

BioMed research international 20190509


<h4>Aims</h4>To compare the efficacy and safety of vonoprazan-based versus proton pump inhibitor (PPI)-based triple therapy in the eradication of <i>Helicobacter pylori</i>.<h4>Methods</h4>We performed a systematic search in PubMed, Embase, and the Cochrane Library databases for relevant randomized controlled trials up to March 2019. Studies were included if they compared the efficacy and safety of <i>H. pylori</i> eradication of vonoprazan-based and PPI-based triple therapy.<h4>Results</h4>Thre  ...[more]

Similar Datasets

| S-EPMC5467706 | biostudies-literature
| S-EPMC9278030 | biostudies-literature
| S-EPMC10196117 | biostudies-literature
| S-EPMC10161293 | biostudies-literature
| S-EPMC9291775 | biostudies-literature
| S-EPMC6207132 | biostudies-literature
| S-EPMC8264245 | biostudies-literature
| S-EPMC10107123 | biostudies-literature
| S-EPMC7214376 | biostudies-literature
| S-EPMC8280045 | biostudies-literature